4 Triple Negative Breast Cancer Clinical Trials in Houston, TX (2026)

Q: How do I join a clinical trial in Houston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you.

Recruiting Triple Negative Breast Cancer Studies in Houston

NCT06022029Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum effective dose (MED) and/or recommended dose for expan...

Houston, TXPHASE1168 participantsOncoNano Medicine, Inc.

View Study Details

NCT07190469Recruiting

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breast cancer (TNBC), and to determine a recom...

Houston, TXPHASE180 participantsProteinQure Inc.

View Study Details

NCT02926690Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

The purpose of this study is to determine the maximum tolerated dose (MTD) of OTS167 administered via oral capsule (PO) to patients with relapsed/refractory locally advanced or metastatic breast cance...

Houston, TXPHASE170 participantsOncoTherapy Science, Inc.

View Study Details

NCT07011654Recruiting

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

This phase I/II trial tests the safety, best dose, and effectiveness of naxitamab in combination with sacituzumab govitecan in treating patients with triple-negative breast cancer (TNBC) that has spre...

Houston, TXPHASE131 participantsM.D. Anderson Cancer Center

View Study Details

About Triple Negative Breast Cancer Clinical Trials in Houston

Triple-negative breast cancer (TNBC) lacks estrogen receptors, progesterone receptors, and excess HER2 protein, limiting targeted treatment options. It accounts for about 10-15% of breast cancers and tends to be more aggressive. Active research focuses on immunotherapy and novel drug combinations.

There are currently 4 triple negative breast cancer clinical trials recruiting participants in Houston, TX. These studies are seeking a combined 349 participants. Research is being sponsored by OncoNano Medicine, Inc., ProteinQure Inc., OncoTherapy Science, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Triple Negative Breast Cancer Clinical Trials in Houston — FAQ

Are there triple negative breast cancer clinical trials in Houston?

Yes, there are 4 triple negative breast cancer clinical trials currently recruiting in Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What triple negative breast cancer treatments are being tested?

The 4 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for triple negative breast cancer.

Data updated October 19, 2026 from ClinicalTrials.gov